Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing frequency important?

BACKGROUND: Twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) may reduce drug adherence compared with once-daily dosing of NOACs in patients with atrial fibrillation (AF), thus worsening clinical outcomes. We evaluated adherence to apixaban and dabigatran requiring twice-dai...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hui-Jeong, Sohn, Il Suk, Jin, Eun-Sun, Bae, Yoon-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062560/
https://www.ncbi.nlm.nih.gov/pubmed/36996134
http://dx.doi.org/10.1371/journal.pone.0283478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062560/
https://www.ncbi.nlm.nih.gov/pubmed/36996134
http://dx.doi.org/10.1371/journal.pone.0283478

Ejemplares similares